The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.

Neck pain and headaches are a package deal for many people. Sometimes the headache is primarily a migraine or tension-type headache, but the neck can still amplify symptoms through muscle guarding, ...

You might've noticed some physiotherapists advertise they offer treatments for headaches and wondered: would that work? In fact, there's a solid body of research showing that physiotherapy treatments ...

Kinesio taping may help reduce pain among patients with musculoskeletal disorders, but the results on total benefit are inconclusive.

One of the most important things I do while assessing patients with musculoskeletal pain is determining their exact location of symptoms. While this seems like a simple inquiry, it requires several ...

The World Health Organization reported in 2022 that approximately 1.71 billion people worldwide were affected by musculoskeletal conditions, making disorders of the spine, joints and connective ...

Musculoskeletal (MSK) disorders affect the muscles, bones, joints, and tissues. In children, they may be due to infection, cancer, inflammatory arthritis, or progressive muscle disorders. MSK ...